Drug shortages in the U.S. have reached an all-time high. A total of 323 shortages were reported during the first quarter of 2024, suggesting that previous strategies had failed to reverse the trend.
The U.K. has committed to a full transition to net zero emissions by 2050, a timeline the BPA says is threatened by a massive backlog of harbor orders.